CS
PRAH

Candriam SCA’s PRA Health Sciences, Inc. PRAH Stock Holding History

Candriam SCA’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-87,515
Closed -$14.5M – 939
2021
Q2 		$14.5M Buy
+87,515
New +$14.6M 0.1% 233

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Candriam SCA's PRAH Position: Q3 2021 in Review

Candriam SCA sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 87,515 shares — an estimated $14.5M sold.

Candriam SCA first reported a position in PRAH in Q2 2021 and held it in 1 quarter. The position peaked at $14.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Candriam SCA reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Candriam SCA sold 87,515 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $14.5M.
  • Candriam SCA first reported a position in PRA Health Sciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Candriam SCA's PRA Health Sciences, Inc. position peaked at $14.5M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.